Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness

American Journal of Public Health

Volumn 91, Issue 1, 2001, Pages 31-37

  Rosenberg, S D ^a   Goodman, L A ^a   Osher, F C ^a   Swartz, M S ^a   Essock, S M ^a   Butterfield, M I ^a   Constantine, N T ^a   Wolford, G L ^a   Salyers, M P ^a  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTPATIENT CARE; SEROPREVALENCE; UNITED STATES;

EID: 0035163889     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.91.1.31     Document Type: Article

References (35)

1. An empirical literature review of definitions of severe and persistent mental illness
2. Defining and counting the chronically mentally ill
3. Epidemiology
4. Comorbidity of mental disorders with alcohol and other drug abuse
5. Prevalence of infection with HIV among the seriously mentally ill: Review of the research and implications for practice
6. HIV seroprevalence among people with severe mental illness in the United States: A critical review
7. HIV infection linked to substance use among hospitalized patients with severe mental illness
8. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994
9. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses
10. Prevalence of HIV infection in the United States, 1984-1992
11. Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital
12. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan
13. Sexual and drug risk behavior
14. Factors associated with risk for HIV infection among chronic mentally ill adults
15. The epidemiology of viral hepatitis in the United States
16. Rising incidence of hepatocellular carcinoma in the United States
17. Assessment of HIV risk
18. Comparison of two instruments for assessing HIV risk in drug abusers
19. The Dartmouth Assessment of Lifestyle Instrument (DALI): A substance use disorder screen for people with severe mental illness
20. Serologic markers of hepatitis B virus infection
21. Hepatitis B
22. Hepatitis C
23. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
24. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone
25. Interferon-ribavirin combination therapy for chronic hepatitis C
26. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: A randomized trial
27. HIV risk reduction interventions for persons with severe mental illness
28. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention
29. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness
30. Review of integrated mental health and substance abuse treatments for patients with dual disorders